Interestingly, higher DSC2 expressing aggregates showed lower apoptotic rates than the corresponding control clusters when treated with cisplatin and, correspondingly, reduced DSC2 expression significantly enhanced tumour cell response to cisplatin. Here, DSC2 is linked to neoplasm.